308 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
CLNX | €31.24 | -2.6% | -5.8% | €22.0b | €44.23 | PS5.5x | E65.4% | 0.2% | Telecom | ||
MRO New | UK£6.43 | 4.2% | 4.0% | UK£8.3b | UK£6.55 | PS2.4x | E100.9% | 0.9% | Capital Goods | ||
ORSTED New | DKK 298.40 | -0.2% | -24.9% | DKK 125.4b | DKK 379.50 | PS1.8x | E31.6% | 0% | Utilities | ||
APG | US$37.50 | -3.3% | 7.4% | US$10.4b | US$44.00 | PS1.5x | E103.6% | n/a | Capital Goods | ||
COHR | US$86.80 | -7.3% | 45.3% | US$13.5b | US$115.97 | PS2.5x | E88.4% | n/a | Tech | ||
DKNG | US$53.49 | 24.9% | 20.0% | US$26.2b | US$54.93 | PS5.5x | E50.6% | n/a | Consumer Services | ||
DLTR | US$71.56 | -3.1% | -50.1% | US$15.4b | US$84.09 | PS0.5x | E33.2% | n/a | Consumer Retailing | ||
A035720 | ₩39,050.00 | -8.1% | -32.9% | ₩17.1t | ₩46,671.43 | PS2.2x | E63.2% | 0.2% | Media | ||
000002 | CN¥7.68 | 3.5% | -22.0% | CN¥86.2b | CN¥7.43 | PS0.2x | E88.5% | 0% | Real Estate Management and Development | ||
GALD | CHF 114.50 | -2.2% | n/a | CHF 27.2b | CHF 107.26 | PS7x | E36.6% | n/a | Pharmaceuticals & Biotech | ||
1COV | €58.50 | 1.1% | 24.5% | €11.0b | €61.82 | PS0.8x | E62.4% | 0% | Materials | ||
NPN New | R4,702.44 | 13.6% | 43.1% | R780.0b | R5,709.04 | PE12.2x | E19.8% | 0.2% | Retail | ||
4755 | JP¥998.40 | 2.1% | 26.0% | JP¥2.2t | JP¥983.00 | PS0.9x | E70.5% | 0% | Retail | ||
2002 New | NT$22.85 | 14.0% | -10.0% | NT$348.4b | NT$23.58 | PE89.2x | E62.8% | 1.5% | Materials | ||
Z74 | S$3.32 | 0.3% | 40.1% | S$54.8b | S$3.72 | PS3.9x | E34.5% | 5.1% | Telecom | ||
UN0 | €44.34 | 3.8% | -20.0% | €18.5b | €34.83 | PS0.2x | E58.7% | 0% | Utilities | ||
TRU New | US$99.74 | 5.4% | 32.9% | US$19.5b | US$117.60 | PE68.4x | E27.6% | 0.5% | Commercial Services | ||
ROKU | US$99.07 | 17.1% | 37.6% | US$14.5b | US$100.06 | PS3.5x | E62.0% | n/a | Media | ||
ILMN | US$100.24 | -4.5% | -30.1% | US$15.9b | US$147.56 | PS3.6x | E56.7% | 3.1% | Pharmaceuticals & Biotech | ||
GMED | US$83.93 | -3.9% | 55.9% | US$11.4b | US$97.85 | PE124.9x | E49.1% | n/a | Healthcare | ||
PHIA | €27.00 | 0.9% | 48.1% | €25.2b | €28.66 | PS1.4x | E63.0% | n/a | Healthcare | ||
GFS | US$43.16 | 14.4% | -19.1% | US$23.9b | US$47.79 | PS3.5x | E42.0% | n/a | Semiconductors | ||
MBLY | US$17.97 | 0% | -29.9% | US$14.6b | US$20.31 | PS8.8x | E106.6% | n/a | Automobiles | ||
UCB | €182.25 | -4.7% | 91.0% | €34.6b | €202.88 | PE144.1x | E28.4% | 0.7% | Pharmaceuticals & Biotech |